NEW YORK (GenomeWeb) – Biodesy said today it has closed a $10 million Series B financing round led by existing investors 5AM Ventures, Pfizer Venture Investments, and Roche Venture Fund.

The company said that proceeds from the round would be used to expand and accelerate commercialization of its Delta System, a high-throughput platform for measuring protein conformational change.

The company also today announced that the platform is now available worldwide.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.

Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.